Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Enovis Corp (ENOV)

Enovis Corp (ENOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,031,007
  • Shares Outstanding, K 54,840
  • Annual Sales, $ 1,707 M
  • Annual Income, $ -33,260 K
  • 60-Month Beta 1.97
  • Price/Sales 1.81
  • Price/Cash Flow 8.83
  • Price/Book 0.90
Trade ENOV with:

Options Overview Details

View History
  • Implied Volatility 36.91% ( -1.63%)
  • Historical Volatility 24.04%
  • IV Percentile 75%
  • IV Rank 69.69%
  • IV High 47.36% on 04/26/23
  • IV Low 12.87% on 09/11/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 904
  • Volume Avg (30-Day) 239
  • Put/Call OI Ratio 6.03
  • Today's Open Interest 9,759
  • Open Int (30-Day) 7,437

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.50
  • Number of Estimates 3
  • High Estimate 0.51
  • Low Estimate 0.49
  • Prior Year 0.44
  • Growth Rate Est. (year over year) +13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.86 +1.77%
on 04/18/24
62.79 -11.08%
on 04/09/24
-3.65 (-6.14%)
since 03/19/24
3-Month
54.86 +1.77%
on 04/18/24
65.03 -14.15%
on 02/22/24
-4.01 (-6.70%)
since 01/19/24
52-Week
43.04 +29.72%
on 10/26/23
66.14 -15.59%
on 07/21/23
-1.43 (-2.50%)
since 04/19/23

Most Recent Stories

More News
EQT PRIVATE EQUITY TO SELL LIMACORPORATE TO ENOVIS: THE ITALIAN SITE IN SAN DANIELE DEL FRIULI WILL REMAIN THE FULCRUM OF PRODUCTION, BENEFITING FROM NEW INVESTMENTS

/PRNewswire/ -- EQT Private Equity announces the sale of LimaCorporate to Enovis. With this transaction, LimaCorporate will become part of the NYSE-listed...

ENOV : 55.83 (+1.01%)
Enovis (ENOV) Q1 Earnings and Revenues Beat Estimates

Enovis (ENOV) delivered earnings and revenue surprises of 18.92% and 4.12%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ENOV : 55.83 (+1.01%)
OLK : 21.87 (-1.80%)
Enovis (ENOV) Beats Q3 Earnings and Revenue Estimates

Enovis (ENOV) delivered earnings and revenue surprises of 25.53% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ENOV : 55.83 (+1.01%)
SMFR : 0.3106 (+26.78%)
Analysts Estimate AllScripts Healthcare (MDRX) to Report a Decline in Earnings: What to Look Out for

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MDRX : 7.6000 (+0.66%)
ENOV : 55.83 (+1.01%)
Will Enovis (ENOV) Beat Estimates Again in Its Next Earnings Report?

Enovis (ENOV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ENOV : 55.83 (+1.01%)
Enovis (ENOV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Enovis (ENOV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ENOV : 55.83 (+1.01%)
AXNX : 66.95 (-0.15%)
Enovis (ENOV) Q2 Earnings Beat Estimates

Enovis (ENOV) delivered earnings and revenue surprises of 20.41% and 1.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

ENOV : 55.83 (+1.01%)
SENS : 0.3992 (-4.04%)
Enovis Announces Second Quarter 2022 Results

Sales of $395 million include 11% reported growth, 3% organic growth and 5% sales-per-day growthReported operating income of $6 million, while...

ENOV : 55.83 (+1.01%)
Pulmonx Corporation (LUNG) Reports Q2 Loss, Tops Revenue Estimates

Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 2.44% and 1.78%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LUNG : 7.51 (+0.13%)
ENOV : 55.83 (+1.01%)
Enovis Launches ARVIS®, Only Augmented Reality Surgical Guidance System Designed Specifically to Improve Both Total Hip and Knee Replacement Surgery

Today, Enovis (NYSE: ENOV), an innovation-driven medical technology company, announced the commercial launch of ARVIS ® (Augmented Reality Visualization and Information System) with over 200 cases...

ENOV : 55.83 (+1.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 57.24
2nd Resistance Point 56.61
1st Resistance Point 56.22
Last Price 55.83
1st Support Level 55.20
2nd Support Level 54.57
3rd Support Level 54.18

See More

52-Week High 66.14
Fibonacci 61.8% 57.32
Last Price 55.83
Fibonacci 50% 54.59
Fibonacci 38.2% 51.86
52-Week Low 43.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar